Red day on Friday for Blueprint Medicines Corporation
(Updated on Dec 03, 2021)
Sell candidate since 2021-12-03 PDF
The Blueprint Medicines Corporation stock price fell by -4.32% on the last day (Friday, 3rd Dec 2021) from $98.51 to $94.25. During the day the stock fluctuated 6.26% from a day low at $93.04 to a day high of $98.86. The price has fallen in 8 of the last 10 days and is down by -14.62% for this period. Volume has increased on the last day by 255 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 615 thousand shares were bought and sold for approximately $57.92 million.
The stock has broken the wide and weak rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $100.99. A reaction back to this level may hold a second chance to get out before further falls.
Signals & Forecast
There are few to no technical positive signals at the moment. The Blueprint Medicines Corporation stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $98.34 and $106.90. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, November 11, 2021, and so far it has fallen -18.74%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $5.82 between high and low, or 6.26%. For the last week, the stock has had a daily average volatility of 5.39%.
Blueprint Medicines Corporation is oversold on RSI14 (14). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.
Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.
Is Blueprint Medicines Corporation stock A Buy?
The Blueprint Medicines Corporation stock holds several negative signals and despite the positive trend, we believe Blueprint Medicines Corporation will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score: -3.517
Predicted Opening Price for Blueprint Medicines Corporation of Monday, December 6, 2021
The predicted opening price is based on yesterday's movements between high, low, and the closing price.
|Fair opening price December 6, 2021||Current price|
Remember To Visit Our YouTube Channel
On Nov 30, 2021 "JMP Securities" gave "$151.00" rating for BPMC. The price target was changed from $95.08 to 3.3%.
BPMC Insider Trading
|Nov 16, 2021||Sell||600||Hurley Ariel||Stock Option (Right to Buy)|
|Nov 16, 2021||Sell||650||Hurley Ariel||Stock Option (Right to Buy)|
|Nov 16, 2021||Sell||700||Hurley Ariel||Stock Option (Right to Buy)|
|Nov 16, 2021||Sell||1 950||Hurley Ariel||Common Stock|
|Nov 16, 2021||Buy||600||Hurley Ariel||Common Stock|
Fibonacci Support & Resistance Levels
Accumulated Volume Support & Resistance Levels
Click to get the best stock tips daily for free!
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy SubscribersDon't miss out on the runners!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.